Android app on Google Play

Deutsche Bank Cuts Price Target In MedTech

October 10, 2011 10:03 AM EDT Send to a Friend
Get Alerts SYK Hot Sheet
Price: $82.14 -0.92%

Rating Summary:
    15 Buy, 17 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 8 | Down: 13 | New: 4
Trade SYK Now!
Join SI Premium – FREE
Deutsche Bank lowered its price targets on a number of Medical Supplies & Devices today.

The firm comments, "The MedTech sector has been under pressure recently on concerns regarding the earnings outlook, particularly given FX rates. We believe sector fundamental are likely to remain challenging and Street EPS ests for some may be lowered to reflect it and FX movements."

In the group, Deutsche Bank highlighted its comfortability with Buy-rated Stryker (NYSE: SYK) which recently reiterated its guidance.

PRICE TARGET CHANGES:
Baxter International Inc. (NYSE: BAX) (Buy) from $68 to $66
Becton, Dickinson and Company (NYSE: BDX) (Hold) from $88 to $85
Boston Scientific Corporation (NYSE: BSX) (Hold) FROM $8.20 to $7.20
Covidien plc (NYSE: COV) (Buy) from $61 to $59
St. Jude Medical Inc. (NYSE: STJ) (Buy) from $57 to $51
Johnson & Johnson (NYSE: JNJ) (Hold) from $73 to $70




You May Also Be Interested In


Related Categories

Analyst Comments

Related Entities

Deutsche Bank, Earnings

Add Your Comment